BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX)

Historical Holders from Q4 2019 to Q3 2025

Symbol: BNTX on Nasdaq
Type / Class: Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
Shares outstanding: 239,647,920
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 50,457,110
Holdings value: $4,972,006,484
% of all portfolios: 0.01%
Number of holders: 252
Number of buys: 102
Number of sells: -124
Average buys %: +0%
Average sells %: -0.01%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Medine GmbH	17.6%		$4,386,515,536		42,178,034		Prof. Ugur Sahin, M.D.	31 Mar 2025

Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	50,457,110	$4,972,006,484	-$321,044,592	$127,877,364	$91,712,196	$98.62	252
2025 Q2	53,756,637	$5,723,405,583	+$241,986,249	$153,066,597	$122,664,590	$106.47	255
2025 Q1	51,766,102	$4,713,883,792	+$16,375,983	$132,657,649	$110,253,125	$91.06	276
2024 Q4	50,762,221	$5,785,970,647	+$270,315,091	$227,255,750	$317,239,583	$113.95	299
2024 Q3	44,146,673	$5,240,957,854	+$448,042,220	$269,360,181	$290,824,060	$118.77	288
2024 Q2	40,965,872	$3,292,084,415	-$3,371,001	$99,059,772	$67,912,036	$80.36	278
2024 Q1	40,861,236	$3,768,152,227	+$21,661,779	$126,105,750	$121,013,550	$92.25	278
2023 Q4	40,542,745	$4,273,885,983	+$369,420,974	$161,043,486	$148,959,056	$105.54	277
2023 Q3	36,919,967	$4,008,689,944	-$40,677,233	$172,944,016	$160,493,872	$108.64	245
2023 Q2	37,381,433	$4,042,183,779	-$207,319,966	$171,770,047	$120,433,434	$107.93	246
2023 Q1	39,079,137	$4,865,003,807	-$130,605,071	$138,060,931	$71,192,323	$124.57	272
2022 Q4	39,706,670	$5,966,384,929	+$387,882,980	$300,771,720	$252,415,698	$150.22	312
2022 Q3	37,131,368	$5,008,892,299	+$489,942,648	$257,972,504	$215,346,200	$134.88	249
2022 Q2	33,416,255	$4,980,080,985	-$212,346,370	$412,535,070	$285,763,620	$149.10	276
2022 Q1	34,519,697	$5,890,695,868	-$225,320,254	$811,942,064	$463,472,728	$170.56	274
2021 Q4	35,195,775	$9,066,882,359	-$433,429,701	$1,549,390,340	$1,161,808,840	$257.80	334
2021 Q3	36,667,998	$10,011,251,135	+$781,975,407	$2,236,442,110	$1,378,661,805	$272.99	328
2021 Q2	33,709,299	$7,548,281,316	+$1,380,454,495	$1,022,439,060	$701,994,036	$223.88	275
2021 Q1	29,716,757	$3,242,039,601	+$922,839,812	$352,583,000	$273,154,000	$109.19	213
2020 Q4	20,695,182	$1,688,417,367	-$282,174,671	$162,842,000	$155,120,000	$81.52	183
2020 Q3	24,274,421	$1,679,824,791	-$160,429,955	$168,342,000	$82,848,000	$69.23	144
2020 Q2	26,613,030	$1,776,088,789	+$1,335,873,540	$23,470,000	$28,348,000	$66.74	108
2020 Q1	6,620,182	$383,744,138	-$108,916,451			$58.40	36
2019 Q4	8,476,761	$285,550,000	+$285,550,000			$33.88	19